In conclusions, we found that the COX-2/sEH dual inhibitor PTUPB suppresses human glioblastoma growth in vitro and in vivo, and dramatically inhibits EGFR signaling pathway and expression of HMMR and stemness markers and regulators. The gene discussed is EGFR; the disease is glioblastoma.